MT-ATP8 Gene Cardiomyopathy Apical Hypertrophic and Neuropathy MT-ATP8 Related Genetic Test
Genetic testing plays a crucial role in diagnosing and managing various genetic conditions. One such test is the MT-ATP8 gene cardiomyopathy, apical hypertrophic, and neuropathy, MT-ATP8 related NGS Genetic Test offered by DNA Labs UAE. This test focuses on mutations in the MT-ATP8 gene, which is responsible for the production of a protein involved in energy production in cells.
Cardiomyopathy, a disease of the heart muscle, can be caused by mutations in the MT-ATP8 gene. Specifically, this test targets a type of cardiomyopathy known as apical hypertrophic cardiomyopathy, characterized by thickening of the heart muscle in the apex of the left ventricle. In addition to cardiomyopathy, mutations in the MT-ATP8 gene can also lead to neuropathy, a condition affecting the nerves and causing symptoms like muscle weakness, numbness, and pain.
The MT-ATP8 gene test utilizes next-generation sequencing (NGS) technology to analyze the DNA sequence of the gene and identify any mutations or changes present. This test is essential for diagnosing individuals with cardiomyopathy, apical hypertrophic, and neuropathy related to MT-ATP8 gene mutations. The results of this genetic test provide confirmation of diagnosis, guide treatment decisions, and offer information about the risk of passing on the condition to future generations.
To undergo the MT-ATP8 gene cardiomyopathy, apical hypertrophic, and neuropathy MT-ATP8 related NGS Genetic Test, patients need to provide a blood sample or extracted DNA. Alternatively, a single drop of blood on an FTA card can also be used. The test has a cost of 4400.0 AED and the report is typically delivered within 3 to 4 weeks.
Before undergoing the test, it is recommended to provide the clinical history of the patient. Additionally, a genetic counseling session is advised to draw a pedigree chart of family members affected by MT-ATP8 gene cardiomyopathy, apical hypertrophic, and neuropathy. This helps in better understanding the genetic inheritance pattern and the potential risk for future generations.
The MT-ATP8 gene cardiomyopathy, apical hypertrophic, and neuropathy MT-ATP8 related NGS Genetic Test is typically ordered by a specialized healthcare provider, such as a geneticist or cardiologist, who has expertise in diagnosing and managing genetic conditions.
In conclusion, the MT-ATP8 gene cardiomyopathy, apical hypertrophic, and neuropathy MT-ATP8 related NGS Genetic Test offered by DNA Labs UAE is a valuable tool for diagnosing and managing individuals with cardiomyopathy and neuropathy related to MT-ATP8 gene mutations. The test utilizes advanced NGS technology and provides important insights into the genetic basis of these conditions, allowing for personalized treatment and informed decision-making.
| Test Name | MT-ATP8 Gene Cardiomyopathy apical hypertrophic and neuropathy MT-ATP8 related Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MT-ATP8 Gene Cardiomyopathy, apical hypertrophic, and neuropathy, MT-ATP8 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-ATP8 Gene Cardiomyopathy, apical hypertrophic, and neuropathy, MT-ATP8 related NGS Genetic DNA Test gene MT-ATP8 |
| Test Details |
MT-ATP8 gene cardiomyopathy, apical hypertrophic, and neuropathy, MT-ATP8 related NGS Genetic Test is a genetic test that looks for mutations in the MT-ATP8 gene. This gene is responsible for providing instructions for making a protein that is involved in the production of energy in cells. Mutations in the MT-ATP8 gene can lead to a condition called cardiomyopathy, which is a disease of the heart muscle. In particular, this test focuses on a type of cardiomyopathy called apical hypertrophic cardiomyopathy, which is characterized by thickening of the heart muscle in the apex of the left ventricle. In addition to cardiomyopathy, mutations in the MT-ATP8 gene can also cause neuropathy, which is a condition that affects the nerves and can lead to symptoms such as muscle weakness, numbness, and pain. The MT-ATP8 gene test uses next-generation sequencing (NGS) technology to analyze the DNA sequence of the gene and identify any mutations or changes that may be present. This test can help diagnose individuals with cardiomyopathy, apical hypertrophic, and neuropathy that are related to mutations in the MT-ATP8 gene. The results of this genetic test can be used to confirm a diagnosis, guide treatment decisions, and provide information about the risk of passing on the condition to future generations. It is typically ordered by a healthcare provider, such as a geneticist or cardiologist, who specializes in the diagnosis and management of genetic conditions. |
